tradingkey.logo

Agape ATP Corp

ATPC
1.240USD
+0.020+1.64%
Market hours ETQuotes delayed by 15 min
62.01MMarket Cap
LossP/E TTM

Agape ATP Corp

1.240
+0.020+1.64%
TradingKey Stock Score
Overall Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Peer Comparison
TradingKey Stock Score
Overall Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Peer Comparison

TradingKey Stock Score of Agape ATP Corp

Currency: USD Updated: 2025-11-05

Key Insights

The company's fundamentals are relatively healthy. Its valuation is considered fairly valued,and institutional recognition is low. Despite an average stock market performance, the company shows strong fundamentals. The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.

Agape ATP Corp's Score

Industry at a Glance

Industry Ranking
159 / 210
Overall Ranking
488 / 4616
Industry
Healthcare Equipment & Supplies

Support & Resistance

No Data

Score Analysis

Current score
Previous score

Analyst Rating

Based on 0 analysts
--
Current Rating
--
Target Price
--
Upside Space
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

Agape ATP Corp Highlights

StrengthsRisks
Agape ATP Corporation is a Malaysia-based investment holding company. The principal activity of the Company is to supply health and wellness products, including supplements to assist in cell metabolism, detoxification, blood circulation, anti-aging and products designed to improve the overall health system of the human body and various wellness programs. The Company offers four series of products: ATP Zeta Health Program, ENERGETIQUE, BEAUNIQUE and E.A.T.S. Its ATP Zeta Health Program is a health program designed to assist in the elimination of various diseases caused by environmental pollutants, unhealthy dietary intake and unhealthy lifestyles. ENERGETIQUE series consists of the energy mask series, hyaluronic acid and mousse facial cleanser. Its BEAUNIQUE product series focuses on the research of its diet’s impact on modifying gene expressions in order to address genetic variations and deliver a personalized nutrigenomic solution for every individual.
Growing
The company is in a growing phase, with the latest annual income totaling USD 1.32M.
High Profit Growth
The company's net income leads the industry, with the latest annual income totaling USD 1.32M.
Fairly Valued
The company’s latest PE is -3.22, at a medium 3-year percentile range.
Institutional Buying
The latest institutional holdings are 169.49K shares, increasing 48.24% quarter-over-quarter.

Financial Health

Currency: USD Updated: 2025-11-05

The company's current financial score is 6.28, which is lower than the Healthcare Equipment & Supplies industry's average of 7.46. Its financial status is stable, and its operating efficiency is low. Its latest quarterly revenue reached 465.50K, representing a year-over-year increase of 48.70%, while its net profit experienced a year-over-year increase of 39.39%.

Score

Industry at a Glance

Previous score
6.28
Change
0

Financials

6.61

Key Metrics

Cash and cash equivalents
Total assets
Total liabilities
Free cash flow
No Data

Quality of Earnings

7.87

Operational Efficiency

2.59

Growth Potential

7.18

Shareholder Returns

7.13

Agape ATP Corp's Company Valuation

Currency: USD Updated: 2025-11-05

The company’s current valuation score is 6.73, which is lower than the Healthcare Equipment & Supplies industry's average of 7.19. Its current P/E ratio is -3.22, which is -54.93% below the recent high of -1.45 and -2280.74% above the recent low of -76.57.

Score

Industry at a Glance

Previous score
6.73
Change
0

Valuation Dimensions

P/E
P/B
P/S
P/CF
Industry Ranking 159/210
No Data

Earnings Forecast

Currency: USD Updated: 2025-11-05

There is no earnings forecast score for this company; the Healthcare Equipment & Supplies industry's average is 7.74.

Score

Industry at a Glance

Previous score
0.00
Change
0

Support & Resistance

No Data
No Data

Financial Forecasting

EPS
Revenue
Net Profit
EBIT
No Data

Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

Price Momentum

Currency: USD Updated: 2025-11-05

The company’s current price momentum score is 3.42, which is lower than the Healthcare Equipment & Supplies industry's average of 6.82. Sideways: Currently, the stock price is trading between the resistance level at 1.35 and the support level at 1.11, making it suitable for range-bound swing trading.

Score

Industry at a Glance

Previous score
3.48
Change
-0.06

Support & Resistance

No Data

Indicators

The Indicators feature provides value and direction analysis for various instruments under a selection of technical indicators, together with a technical summary.

This feature includes nine of the commonly used technical indicators: MACD, RSI, KDJ, StochRSI, ATR, CCI, WR, TRIX and MA. You may also adjust the timeframe depending on your needs.

Please note that technical analysis is only part of investment reference, and there is no absolute standard for using numerical values to assess direction. The results are for reference only, and we are not responsible for the accuracy of the indicator calculations and summaries.

Indicators
Sell(3)
Neutral(4)
Buy(0)
Indicators
Value
Direction
MACD(12,26,9)
0.005
Neutral
RSI(14)
48.568
Neutral
STOCH(KDJ)(9,3,3)
32.063
Neutral
ATR(14)
0.066
Low Volatility
CCI(14)
5.489
Neutral
Williams %R
66.667
Sell
TRIX(12,20)
-0.057
Sell
StochRSI(14)
60.926
Sell
Moving Average
Sell(3)
Neutral(0)
Buy(3)
Indicators
Value
Direction
MA5
1.212
Buy
MA10
1.229
Buy
MA20
1.220
Buy
MA50
1.254
Sell
MA100
1.306
Sell
MA200
1.394
Sell

Institutional Confidence

Currency: USD Updated: 2025-11-05

Score

Industry at a Glance

Previous score
3.00
Change
0

Institutional Shareholding

No Data

Shareholder Activity

Name
Shares Held
Chg %
Lesser Panda Ltd
3.68M
--
Global Fartech Ltd
3.45M
--
Nexus Investments Group Ltd
3.04M
--
Oceanic Equity Partner Ltd
3.03M
--
Blue Horizon Capital Ltd
3.03M
--
Global Ascend Ventures Ltd
3.02M
--
Vanguard Development Holdings Ltd
3.02M
--
Evergreen Strategic Capital Holding Ltd
3.01M
--
Choong (How Kok)
980.45K
+0.06%
HKC Talent, Ltd
385.75K
-6.43%
1
2

Risk Assessment

Currency: USD Updated: 2025-11-05

The company’s current risk assessment score is 2.93, which is lower than the Healthcare Equipment & Supplies industry's average of 4.57. The company's beta value is 0.00. This indicates that the stock tends to underperform the index during upward trending markets but experiences smaller declines during downward trending markets.

Score

Industry at a Glance

Previous score
2.93
Change
0
Beta vs S&P 500 index
--
VaR
--
240-Day Maximum Drawdown
+53.47%
240-Day Volatility
+170.64%

Return

Best Daily Return
60 days
+7.89%
120 days
+36.67%
5 years
--
Worst Daily Return
60 days
-6.49%
120 days
-28.57%
5 years
--
Sharpe Ratio
60 days
-0.77
120 days
-0.79
5 years
--

Risk Assessment

Maximum Drawdown
240 days
+53.47%
3 years
--
5 years
--
Return-to-Drawdown Ratio
240 days
-0.24
3 years
--
5 years
--
Skewness
240 days
+2.96
3 years
--
5 years
--

Volatility

Realised Volatility
240 days
+170.64%
5 years
--
Standardised True Range
240 days
+12.45%
5 years
--
Downside Risk-Adjusted Return
120 days
-106.56%
240 days
-106.56%
Maximum Daily Upside Volatility
60 days
+48.49%
Maximum Daily Downside Volatility
60 days
+34.28%

Liquidity

Average Turnover Rate
60 days
+0.10%
120 days
+1.31%
5 years
--
Turnover Deviation
20 days
--
60 days
--
120 days
--

Peer Comparison

Healthcare Equipment & Supplies
Agape ATP Corp
Agape ATP Corp
ATPC
3.86 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Castle Biosciences Inc
Castle Biosciences Inc
CSTL
8.65 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Cencora Inc
Cencora Inc
COR
8.61 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
TCMD
8.60 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
AxoGen Inc
AxoGen Inc
AXGN
8.53 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Artivion Inc
Artivion Inc
AORT
8.51 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
View more
KeyAI